83°

Topics

Pharmaceutical Industry
Amgen to cut at least 2,400 jobs, close plants
Amgen to cut at least 2,400 jobs, close plants

Biologic drugmaker Amgen said Tuesday that it will lay off 12 percent to 15 percent of its worldwide workforce and close four sites, even as it reported very strong second-quarter results that trounced Wall Street expectations. The maker of Prolia for osteoporosis and anemia treatment Aranesp said it's restructuring to free up money needed for investments in the business, particularly marketing costs for launching new drugs. The layoffs will happen this year and next, eliminating 2,400 to 2,900 jobs, mostly in the U.S. Amgen also plans to close two sites in Colorado, primarily manufacturing plants, and two in Washington state that focus on research and development. Amgen said it...

Loading